Skip to main content

Featured

Best Budget Phone Plans in Canada Under $35/Month (2026)

$29 Lucky Mobile 65 GB · Bell LTE · Best Value $29 Chatr 50 GB · Rogers LTE $29 Fizz 50 GB · 4G · ON/BC/AB $34 Chatr 80 GB · Rogers LTE · Most Data $35 Public Mobile 25 GB · 5G · US & MX included Canadians pay some of the highest mobile rates in the world — or at least, they used to. Budget carriers and flanker brands have quietly been slashing prices and packing in data throughout 2026, and today there are legitimate plans under $35/month that include unlimited talk & text, 5G speeds, and tens of gigabytes of data . The catch? These deals live on the websites of smaller brands like Lucky Mobile, Chatr, Fizz, and Public Mobile — not the Rogers/Bell/Telus homepage you're probably used to. They all run on the exact same Big Three towers, and most don't require a contract or credit check. You just need to Bring Your Own Device (BYOD). Pro Tip — Autopay = More Data: Almost every plan below requires automatic top-up or autopay enabled to qualify for the advertised price a...
Post a Comment
Read more

article

Labels

Revolutionary Gene Therapy Restores Hearing in Deaf Toddler

 

In a remarkable medical breakthrough, an 18-month-old toddler named Opal Sandy has regained her hearing thanks to a pioneering gene therapy trial. Born deaf due to a rare genetic condition affecting the OTOF gene, which is responsible for producing a protein essential for hearing, Opal’s prospects for natural hearing were bleak. However, the innovative treatment at Cambridge University Hospitals in England has opened up a world of sound for her.

The procedure involved the infusion of a working copy of the OTOF gene into Opal’s right ear, a process that took a mere 16 minutes. Remarkably, within weeks, Opal began responding to loud noises, and after 24 weeks, she could hear whispers, indicating a near-normal level of hearing restoration.

Opal’s case is part of the Chord trial, which is recruiting more children from the UK, Spain, and the US to undergo similar treatment. The trial is being closely monitored, with participants followed up for five years to assess the long-term efficacy and safety of the therapy.

The success of this gene therapy is a beacon of hope for many suffering from genetic deafness, signaling the dawn of a new era in medical science where conditions once thought incurable are now within the realm of treatment. Opal’s story is not just a personal victory; it’s a milestone in genetic medicine, showcasing the incredible potential of gene therapy to change lives.

Labels:

Comments

Post a Comment